On Aug. 13, 2021, Rigel Pharma announced that the U.S. Food and Drug Administration (FDA) had informed the…
On Aug. 13, 2021, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved TICOVACﾙ (tick-borne…
On Aug. 13, 2021, Merck announced that the U.S. Food and Drug Administration (FDA) had approved WELIREG, an…
On Aug. 12, 2021, Innovation Pharma released information regarding the status of its randomized, double-blind, placebo-controlled Phase 2…
On Aug. 12, 2021, Moderna announced the publication of new data on the durability of the Moderna COVID-19…
On Aug. 12, 2021, the U.S. Department of Veterans Affairs (VA) announced that it expanded his previous COVID-19…
On Aug. 11, 2021, the National Institutes of Health (NIH) announced that one dose of a new monoclonal…
On Aug. 11, 2021, the World Health Organization (WHO) announced the next phase in its Solidarity trial that…
On Aug. 10, 2021, Cardinal Health announced its efforts to commercialize and broaden access to over-the-counter rapid COVID-19…
On Aug. 10, 2021, Moderna announced a Memorandum of Understanding (MoU) with the government of Canada to build…
On Aug. 10, 2021, the National Institutes of Health (NIH) announced that a pilot study had begun to…
On Aug. 9, 2021, Inovio Pharma announced that it had received regulatory allowance for two clinical trials investigating…
On Aug. 9, 2021, health authorities in Guinea confirmed a case of Marburg virus disease in the southern…
On Aug. 9, 2021, Moderna announced that the Therapeutic Goods Administration (TGA) had granted provisional registration to the…
On Aug. 6, 2021, the Centers for Disease Control and Prevention (CDC) annouced in MMWR that a study…
On Aug. 6, 2021, BD (Becton, Dickinson) and CerTest Biotec announced the CE mark for a molecular test…
On Aug. 6, 2021, the U.S. Food and Drug Administration approved Genzyme’s Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion…
On Aug. 5, 2021, Novavax announced preliminary data demonstrating that a single booster dose of its recombinant nanoparticle…
On Aug. 5, 2021, an international team of researchers announced that a mutation in a single gene appeared…
On Aug. 4, 2021, Inovio Pharma announced that the company had dosed the first Phase 2 trial subject…
On Aug. 4, 2021, Humanigen announced analysis of results from its Phase 3 LIVE-AIR study of lenzilumab in…
On Aug. 4, 2021, Novavax announced that it had reached an agreement with the European Commission (EC) for…
On Aug. 4, 2021, Bio-Techne announced that scientists at the U.S. Centers for Disease Control and Prevention (CDC)…
On Aug. 4, 2021, Regeneron announced that the New England Journal of Medicine (NEJM) had published positive detailed…
On Aug. 3, 2021, CytoDyn announced that Brazil’s regulatory authority ANVISA (Agência Nacional de Vigilância Sanitária) has approved…
On Aug. 3, 2021, Illumina announced it had donated US $1 million in sequencing capabilities to the Molecular…
On Aug. 3, 2021, Vanda Pharmaceuticals announced that enrollment had closed in the ODYSSEY study comparing tradipitant and…
On Aug. 3, 2021, Eli Lilly and Incyte announced results from an additional cohort of 101 adult patients…
On Aug. 2, 2021, Vaxart announced that the U.S. Food and Drug Administration had cleared Vaxart’s Investigational New…
On Jul. 30, 2021, Humanigen announced that the NIH had advanced the ACTIV-5/BET-B study to a Phase 2/3…